CRISPR Therapeutics AG CRSP 26.86
Health Care · NASDAQ · Data as of 2026-08-03
CRISPR Therapeutics AG (CRSP) has delivered +6.5% annualized revenue growth, n/a earnings growth, and n/a dividend growth over 10 years of data. Ranked #1926 of 1968 stocks overall and #249 of 260 in the Health Care sector by Steady Score.
Industry
Biological Products
Steady Score
26.86
Overall Rank
#1926 / 1968
Sector Rank
#249 / 260
Revenue CAGR
+6.5%
Earnings CAGR
-
Dividend CAGR
-
?
E/R CAGR Ratio
-
Revenue
Earnings
Dividends
Free Cash Flow
Margin
NET Margin
FCF Margin
Payout Ratio
Payout Ratio
FCF Payout Ratio